144 reports of this reaction
2.9% of all POLYMYXIN B SULFATE reports
#7 most reported adverse reaction
VOMITING is the #7 most commonly reported adverse reaction for POLYMYXIN B SULFATE, manufactured by FOSUN PHARMA USA INC. There are 144 FDA adverse event reports linking POLYMYXIN B SULFATE to VOMITING. This represents approximately 2.9% of all 5,004 adverse event reports for this drug.
Patients taking POLYMYXIN B SULFATE who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VOMITING is a less commonly reported adverse event for POLYMYXIN B SULFATE, but still significant enough to appear in the safety profile.
In addition to vomiting, the following adverse reactions have been reported for POLYMYXIN B SULFATE:
The following drugs have also been linked to vomiting in FDA adverse event reports:
VOMITING has been reported as an adverse event in 144 FDA reports for POLYMYXIN B SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
VOMITING accounts for approximately 2.9% of all adverse event reports for POLYMYXIN B SULFATE, making it a notable side effect.
If you experience vomiting while taking POLYMYXIN B SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.